Citation: Ne. Hynes et Ha. Lane, Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptortyrosine kinase, J MAMMARY G, 6(1), 2001, pp. 141-150
Citation: R. Brandt et al., Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells providea novel orthotopic tumor model for testing anti-cancer agents, ONCOGENE, 20(39), 2001, pp. 5459-5465
Authors:
Lane, HA
Motoyama, AB
Beuvink, I
Hynes, NE
Citation: Ha. Lane et al., Modulation of p27/Cdk2 complex formation through 4D5-mediated inhibition of HER2 receptor signaling, ANN ONCOL, 12, 2001, pp. 21-22
Citation: K. Horsch et al., The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells, MOL ENDOCR, 15(12), 2001, pp. 2182-2196
Authors:
Olayioye, MA
Badache, A
Daly, JM
Hynes, NE
Citation: Ma. Olayioye et al., An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway, EXP CELL RE, 267(1), 2001, pp. 81-87
Citation: A. Badache et Ne. Hynes, Interleukin 6 inhibits proliferation and, in cooperation with an epidermalgrowth factor receptor autocrine loop, increases migration of T47D breast cancer cells, CANCER RES, 61(1), 2001, pp. 383-391
Authors:
Yen, L
You, XL
Al Moustafa, AE
Batist, G
Hynes, NE
Mader, S
Meloche, S
Alaoui-Jamali, MA
Citation: L. Yen et al., Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis, ONCOGENE, 19(31), 2000, pp. 3460-3469
Citation: N. Cella et al., Lactogenic hormones and tenascin-C regulate C/EBP alpha and beta in mammary epithelial cells, J CELL BIOC, 76(3), 2000, pp. 394-403
Authors:
Lane, HA
Beuvink, I
Motoyama, AB
Daly, JM
Neve, RM
Hynes, NE
Citation: Ha. Lane et al., ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: Receptor overexpression does not determine growth dependency, MOL CELL B, 20(9), 2000, pp. 3210-3223
Authors:
Spencer, KSR
Graus-Porta, D
Leng, J
Hynes, NE
Klemke, RL
Citation: Ksr. Spencer et al., ErbB2 is necessary for induction of carcinoma cell invasion by ErbB familyreceptor tyrosine kinases, J CELL BIOL, 148(2), 2000, pp. 385-397
Authors:
Beuvink, I
Hess, D
Flotow, H
Hofsteenge, J
Groner, B
Hynes, NE
Citation: I. Beuvink et al., Stat5a serine phosphorylation - Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity, J BIOL CHEM, 275(14), 2000, pp. 10247-10255
Authors:
Daly, JM
Olayioye, MA
Wong, AML
Neve, R
Lane, HA
Maurer, FG
Hynes, NE
Citation: Jm. Daly et al., NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways, ONCOGENE, 18(23), 1999, pp. 3440-3451
Authors:
Klapper, LN
Glathe, S
Vaisman, N
Hynes, NE
Andrews, GC
Sela, M
Yarden, Y
Citation: Ln. Klapper et al., The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors, P NAS US, 96(9), 1999, pp. 4995-5000
Authors:
Olayioye, MA
Beuvink, I
Horsch, K
Daly, JM
Hynes, NE
Citation: Ma. Olayioye et al., ErbB receptor-induced activation of Stat transcription factors is mediatedby Src tyrosine kinases, J BIOL CHEM, 274(24), 1999, pp. 17209-17218